BioWisdom Joins $14.5M European Alzheimer Biomarker Project | GenomeWeb

NEW YORK, May 4 (GenomeWeb News) - Cambridge, UK-based BioWisdom said today that it will join the AddNeuroMed project of the European Commission's Innovative Medicines for Europe consortium, where it will use its Sofia software platform to help identify and validate Alzheimer's disease biomarkers.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.